Joji Samejima

5PUBLICATIONS
24CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY).

Keiju Aokage, Shohei Koyama, Shogo Kumagai

|Mar 08, 2024
Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non-small cell lung cancer.

Yusuke Nagasaki, Tetsuro Taki, Kotaro Nomura

|Jan 06, 2024
Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer.

Takahiro Niimi, Joji Samejima, Masashi Wakabayashi

|Mar 05, 2020
Desmoid-type fibromatosis arising from thoracotomy incision.

Joji Samejima, Hiroyuki Ito, Tomoyuki Yokose

Pageof 1